National Health Investors (NYSE:NHI) Price Target Increased to $65.00 by Analysts at Truist Financial

National Health Investors (NYSE:NHI) had its target price raised by analysts at Truist Financial from $58.00 to $65.00 in a report released on Wednesday, Benzinga reports. The firm presently has a “hold” rating on the real estate investment trust’s stock. Truist Financial’s price target would indicate a potential downside of 3.85% from the company’s previous close.

A number of other equities research analysts have also recently commented on the stock. StockNews.com cut shares of National Health Investors from a “buy” rating to a “hold” rating in a report on Thursday, April 18th. BMO Capital Markets raised National Health Investors from a “market perform” rating to an “outperform” rating and set a $67.00 target price for the company in a report on Tuesday, March 12th. Wells Fargo & Company upped their price target on National Health Investors from $63.00 to $69.00 and gave the company an “overweight” rating in a report on Thursday, May 30th. Finally, Wedbush lifted their price objective on National Health Investors from $64.00 to $66.00 and gave the stock an “outperform” rating in a report on Monday, March 18th. Five investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $62.13.

National Health Investors Stock Performance

Shares of NHI stock opened at $67.60 on Wednesday. The company has a market capitalization of $2.94 billion, a price-to-earnings ratio of 22.16 and a beta of 1.00. The company has a debt-to-equity ratio of 0.91, a quick ratio of 13.24 and a current ratio of 13.24. National Health Investors has a one year low of $48.51 and a one year high of $68.14. The company’s 50-day moving average is $65.37 and its 200 day moving average is $59.89.

Insider Activity

In other National Health Investors news, Director Robert A. Mccabe, Jr. bought 437 shares of the business’s stock in a transaction that occurred on Friday, May 31st. The stock was bought at an average cost of $65.83 per share, for a total transaction of $28,767.71. Following the completion of the transaction, the director now owns 21,585 shares of the company’s stock, valued at approximately $1,420,940.55. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 7.26% of the company’s stock.

Hedge Funds Weigh In On National Health Investors

Institutional investors and hedge funds have recently bought and sold shares of the stock. Lasalle Investment Management Securities LLC raised its stake in shares of National Health Investors by 8.4% in the first quarter. Lasalle Investment Management Securities LLC now owns 508,035 shares of the real estate investment trust’s stock worth $31,920,000 after buying an additional 39,554 shares during the period. Tidal Investments LLC increased its holdings in National Health Investors by 22.4% in the 1st quarter. Tidal Investments LLC now owns 4,701 shares of the real estate investment trust’s stock worth $291,000 after acquiring an additional 861 shares in the last quarter. Benchmark Investment Advisors LLC bought a new stake in National Health Investors during the 1st quarter worth approximately $314,000. Price T Rowe Associates Inc. MD boosted its position in shares of National Health Investors by 6.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 26,836 shares of the real estate investment trust’s stock worth $1,687,000 after purchasing an additional 1,516 shares during the period. Finally, CANADA LIFE ASSURANCE Co increased its stake in shares of National Health Investors by 2.3% in the first quarter. CANADA LIFE ASSURANCE Co now owns 55,985 shares of the real estate investment trust’s stock worth $3,518,000 after purchasing an additional 1,248 shares in the last quarter. 62.51% of the stock is currently owned by hedge funds and other institutional investors.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.